GW856553

· GlaxoSmithKline

Drug timelines are a Plus or Pro feature.

10 regulatory and trial events tracked for GW856553, covering 2012-06-04 to 2018-10-17. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Effects of 3 Months Dosing With GW856553, as Assessed FDG-PET/CT Imaging [Phase 2]